The new washer features a large loading capacity and a functional, compact design.
Miele has introduced the PLW 86xx, a large chamber laboratory washer that features a large loading capacity and a functional, compact design.
The washer comes equipped with a variable speed circulation pump, a flush-fitted 7” control panel with three-color interior chamber lighting, and the option to add on a high-efficiency particulate air (HEPA) H14 filter, steam condenser, and a printer, according to a Feb. 17, 2020 company press release. Additionally, the new design introduces water and power savings with separate recycling and pre-heating tanks that reuse the final rinse water and make sure the water is available at the required temperature, which reduces cycle time, according to the company.
“This range offers very significant savings on utilities, right from the first wash, which really mount up over time,” said Dr. Bernd Eschweiler of Miele, in the press release. “Plus the EasyLoad accessory range makes them highly flexible-able to safely and simply accommodate items from 5-mL vials to 50-L carboys. Its environmental benefits are also proving attractive. As well as offering impressive energy and water savings, the machines are built from 93% fully recyclable materials.”
Source: Miele
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.